Vigabatrin-Associated Visual Field Defects

J Gordon Millichap

doi:10.15844/pedneurbriefs-15-12-9

Vigabatrin-Associated Visual Field Defects

Pediatric Neurology Briefs

Volume 15 (2001): Issue 12

By: J Gordon Millichap

Open Access

|Dec 2001

Abstract

The prevalence, risk factors, and long-term outcome of vigabatrin-associated visual field defects were examined in 60 adult patients with partial epilepsy treated with vigabatrin for 7 months to 14 years at the University of Kuopio Hospital, Finland.

References

Nousiainen I Mäntyjärvi M Kälviäinen R No reversion in vigabatrin-associated visual field defects Neurology 2001 Nov 27 57 10 1916 7 10.1212/WNL.57.10.1916 11723291
Open DOI Search in Google Scholar Back to article
Giordano L Valseriati D Vignoli A Morescalchi F Gandolfo E Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor? Neurol Sci 2000 Jun 21 3 185 6 10.1007/s100720070096 11076009
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-15-12-9 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 94 - 95

Published on: Dec 1, 2001

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Kinetic Goldmann Perimetries,

Visual Field Constriction,

Bilateral Concentric Defects

© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 15 (2001): Issue 12